Related Experiment Videos
Fentanyl therapy controls autonomic hyperactivity in tetanus
A V Moughabghab1, G Prevost, C Socolovsky
1Service de Réanimation, Centre Hospitalier General de Valenciennes, France.
The British Journal of Clinical Practice
|December 1, 1996
Summary
Fentanyl effectively managed severe tetanus with autonomic hyperactivity when standard treatments failed. This opioid analgesic offers a successful therapeutic option for critical tetanus cases, improving patient outcomes.
Area of Science:
- Anesthesiology
- Critical Care Medicine
- Pharmacology
Background:
- Severe tetanus presents significant risks, including cardiovascular instability due to sympathetic overactivity.
- Established treatments like heavy sedation, neuromuscular blockade, and ventilation may fail in critical tetanus cases.
- Autonomic hyperactivity in tetanus is linked to a mortality rate exceeding 50%.
Observation:
- A case of severe generalized tetanus in an adult patient exhibited significant autonomic hyperactivity.
- Conventional therapeutic modalities for tetanus were unsuccessful in managing this patient's condition.
- The patient experienced severe cardiovascular instability.
Findings:
- High-dose intravenous fentanyl administration successfully managed the severe tetanus case.
- Fentanyl demonstrated efficacy in controlling cardiovascular instability and autonomic hyperactivity associated with tetanus.
- This approach provided a successful alternative when other treatments failed.
Implications:
- Intravenous fentanyl can be a valuable therapeutic option for severe tetanus cases refractory to standard care.
- Effective management of autonomic hyperactivity is crucial for improving survival rates in severe tetanus.
- Further research into opioid-based strategies for tetanus management is warranted.